New Zealand markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0900+0.0700 (+1.74%)
At close: 04:00PM EDT
4.0900 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 290.92M
Enterprise value 204.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.22
Price/book (mrq)3.65
Enterprise value/revenue 4.15
Enterprise value/EBITDA -15.50

Trading information

Stock price history

Beta (5Y monthly) 1.79
52-week change 3-70.57%
S&P500 52-week change 3-13.03%
52-week high 314.4900
52-week low 32.9100
50-day moving average 33.5820
200-day moving average 35.9992

Share statistics

Avg vol (3-month) 3701.84k
Avg vol (10-day) 3593.7k
Shares outstanding 576.76M
Implied shares outstanding 6N/A
Float 870.39M
% held by insiders 10.66%
% held by institutions 158.75%
Shares short (14 Jun 2022) 43.51M
Short ratio (14 Jun 2022) 45.08
Short % of float (14 Jun 2022) 44.98%
Short % of shares outstanding (14 Jun 2022) 44.57%
Shares short (prior month 12 May 2022) 43.91M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -45.00%
Operating margin (ttm)-153.22%

Management effectiveness

Return on assets (ttm)-21.95%
Return on equity (ttm)-27.22%

Income statement

Revenue (ttm)49.37M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)79.60%
Gross profit (ttm)-10.97M
EBITDA -73.31M
Net income avi to common (ttm)-22.22M
Diluted EPS (ttm)-1.0170
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)145.42M
Total cash per share (mrq)1.89
Total debt (mrq)59.23M
Total debt/equity (mrq)74.22
Current ratio (mrq)7.29
Book value per share (mrq)1.04

Cash flow statement

Operating cash flow (ttm)-66.79M
Levered free cash flow (ttm)-40.27M